MRNA240927C61000
- 3.35
- -0.90-21.18%
Moderna Newsroom
Moderna (MRNA) Stock Slides as Market Rises: Facts to Know Before You Trade
Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today
'Mpox Cases Double In Los Angeles County, Health Officials Urge Vaccination; Los Angeles County Public Health Officials Report Increase, Recommend Prevention Measures' - Pasadena Now
Biden On Sudan Says End This War Now; Let's Move Quickly To Face Mpox Outbreak In Africa
President Biden Will Announce Donation Of 1M MPox Vaccine Doses, At Least $500M To African Countries To Support Their Response To Outbreak
CDC Says No Cases Of Clade IA Mpox Have Been Reported Outside Central African Countries Where Clade IA MPVX Is Endemic
How to Get Free At-Home Covid-19 Tests -- Barrons.com
Top 3 Health Care Stocks That May Explode This Month
Bridgewater Unloads Lilly and Apple Shares -- Barron's
Deutsche Bank Cuts Moderna Price Target to $75 From $80
Express News | EMA's Chmp: Positive Opinions to Update Composition of Mrna Vaccine Spikevax1, to Target Sars-Cov-2 Jn.1 Variant, Comirnaty for Kp.2 Subvariant
Down 13% in 1 Day, Is Moderna Stock in Trouble?
Dow, S&P 500 Close at Record Highs
'EMA Recommends Extending Indication Of Mpox Vaccine To Adolescents' - EMA
RBC Capital Reiterates Sector Perform on Moderna, Maintains $75 Price Target
Moderna Analyst Ratings
RBC Capital Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $75
RBC Capital analyst Luca Issi maintains $Moderna(MRNA.US)$ with a hold rating, and adjusts the target price from $90 to $75.According to TipRanks data, the analyst has a success rate of 22.6% and a
Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks
10 Health Care Stocks With Whale Alerts In Today's Session
UBS Highlights 30 Stocks Poised for Potential Moves After the Fed's Expected Rate Cut